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Abstract
Aims: To provide updated knowledge on the relationship between periodontal disease and diabetes from an oral 
health perspective.
Methods: A review of the �nglish-language literature was performed, gathering articles on the two diseases pub-
lished over the past 10 years.
Results: Both diseases result from the confluence of various triggering and modifying factors, and there are inter-
individual differences in the risk of their development. Recent research has shown that diabetes may increase the 
risk of periodontitis, and it has been proposed that chronic periodontal disease may influence the natural course of 
diabetes. There appears to be an association among oral infections, impaired sugar metabolism, and atherosclero-
sis, indicating a theoretical link between metabolic syndrome and periodontal disease. 
Clinical implications: Control of periodontal disease may enhance glycemic control in patients with type 2 diabe-
tes. In turn, improved glycemic control may contribute to a better control of periodontal disease.
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Introduction
This review outlines the characteristics of diabetes and 
periodontal disease, explores their known interrelation-
ships, and discusses the scientific evidence, mainly fo-
cusing on clinical research.
The relationship between periodontitis and diabetes has 
been extensively investigated over the past few decades 
(1). Nevertheless, the impact of periodontal treatment 
on glycemic control in diabetics has not been fully elu-
cidated. Although there have been numerous scientific 
studies on the influence of periodontal treatments on 
glycemic control, there is limited knowledge on the ef-
fects of glycemic control on periodontal status. This 
review not only shows data about recent knowledge of 
these two pathologies, but also highlights the need for 
further research to elucidate this  interaction.
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The aim of the review was to provide updated knowl-
edge on these topics from an oral health perspective. 
We reviewed all articles related to these two diseases 
published in �nglish over the past 10 years, using the 
National Library of Medicine �ntrez PubMed search 
engine for the literature search.
Diabetes mellitus
Diabetes mellitus is a metabolic disease usually charac-
terized by the classic triad of polydipsia, polyuria and 
polyphagia, consequences of homeostasis disruption due 
to impaired glucose metabolism. It is difficult to establish 
the prevalence in the general population, which has been 
estimated at 1- 6% according to the diagnostic criteria 
used. Approximately 90% of cases correspond to patients 
with non-insulin dependent type-2 diabetes (2).
The impaired metabolism of glucose, lipids, and pro-
teins in diabetes produces alterations in macro- and mi-
cro-vascular circulation that are associated with the five 
classic complications of the disease, i.e., retinopathy, 
neuropathy, nephropathy, cardiovascular complications, 
and delayed wound-healing (1). Periodontal disease has 
been proposed as the sixth complication of diabetes, 
based on the highly frequent presence of both diseases 
in the same patient (2-4). However, some aspects of this 
association remain controversial.
Classification
There are two main types of diabetes, insulin-dependent 
type-1 diabetes and non-insulin-dependent type-2 diabe-
tes. Despite their designations, this classification does not 
solely depend on the need for exogenous insulin, which 
can sometimes also be required by type-2 patients (5). 
Type-1 diabetes is produced by the destruction of insulin-
producing cells, whereas type-2 results from the combi-
nation of an increase in cell resistance to endogenous 
insulin with a defective secretion of this substance. Most 
dental researchers have addressed type-1 diabetes, and 
studies of type-2 diabetes from an oral health perspective 
have only been published since the mid-1990s. 
Etiology and pathogenesis
The following two mechanisms have been proposed to 
explain the classic complications of diabetes (2). 
1) Polyol pathway.
According to this theory, glucose is converted into sorb-
itol by the action of aldose reductase, which is impli-
cated as the toxin in almost all of these complications. 
2) Production of advanced glycosylation end products 
(AG�s).
This second theory proposes that glucose binds to pro-
teins, lipids, and nucleic acids, giving rise to AG�s that 
alter their functions. Thus, the binding of glucose to 
hemoglobin, collagen, or albumin produces complica-
tions according to the organ in which AG�s are depos-
ited (e.g., kidney, nervous system, vascular system, or 
retina, among others). 
Periodontal disease
Periodontal disease is an entity of localized infections 
that involve tooth supporting tissues, the structures 
that make up the periodontium (i.e., gingiva, periodon-
tal ligament, root cementum, and alveolar bone). The 
designation periodontal disease includes both reversible 
(gingivitis) and irreversible (periodontitis) processes. 
In periodontitis, there is destruction of the connective 
tissue of the tooth attachment apparatus accompanied 
by apical migration of the apparatus and eventual tooth 
loss.
The first clinical manifestation of periodontal disease 
is the appearance of periodontal pockets, which offer a 
favorable niche for bacterial colonization. It can be di-
agnosed by clinical examination with periodontal probe 
to determine pocket depths in combination with X-ray 
imaging, using microbiological techniques for a precise 
analysis of the infectious agents.
 The clinical importance of periodontal disease derives 
in part from its very high prevalence. Although variable 
data have been published, most studies in the USA, for 
example, have reported that half of the population has 
some history of gingivitis and that 14% of them suf-
fer from periodontal disease (3). In fact, the figures for 
periodontal disease may underestimate its true preva-
lence, since earlier studies had found that 25-36% of the 
population was affected. �stimations of the epidemiol-
ogy of this disease appear to depend on the diagnostic 
approach adopted (2).
Classification
Variability in the diagnosis of the disease is in part 
caused by the lack of an adequate classification. Several 
attempts have been made to classify periodontal disease 
according to its etiology and clinical manifestations (6), 
considering periodontal disease as an entity independ-
ent from the patient  that is capable of producing signs 
and symptoms (7,8). The 1999 American Association of 
Periodontology (AAP) classification, currently the most 
widely used, identifies six categories: gingival disease, 
chronic periodontitis, aggressive periodontitis, peri-
odontitis as manifestation of systemic disease, necrotiz-
ing periodontal disease, and periodontal abscess (6).
Drawbacks of both the 1989 and 1999 AAP proposals 
are that periodontal disease cannot be classified accord-
ing to its etiology, and there are no well-defined clini-
cal criteria for its diagnosis, leaving this decision to the 
healthcare professional (8).
Etiology and pathogenesis
According to current concepts of the multifactorial eti-
ology of periodontal disease, it is caused by the interac-
tion among single or multiple microbial agents (neces-
sary but not sufficient primary etiologic factors), a host 
with some degree of susceptibility, and environmental 
factors with an influence on both. Although a single 
model of the etiopathogeny of periodontal disease has 
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yet to be validated, it is broadly accepted that periodon-
tal disease results from action of the bacterial biofilm on 
the periodontium of the susceptible individual. Bacteria 
are able to survive and grow in the complex ecosystem 
of this biofilm because of their production of virulence 
factors. These factors also confer a greater resistance to 
host defense mechanisms, i.e., they increase the capac-
ity of the bacteria to overcome the inflammatory reac-
tion and immune response to antigen presentation (9).
Although there have been some reports of tissue dam-
age caused by the presence of bacteria in situ, i.e., in 
the affected tissue itself, it is more commonly observed 
at some distance from the bacteria, demonstrating their 
capacity for indirect action. Bacteria appear to act di-
rectly during the first moments of infection. However, 
most of their activity is indirect, via cell and humoral 
components of specific and non-specific host responses 
to protect the biofilm (10).
According to a review by  Offenbacher in 1996, the 
presence of bacteria in the periodontal pocket triggers a 
reaction that starts with intervention of the neutrophil-
antibody-complement axis, stimulating different cell 
types (11). Thus, neutrophils attempt to phagocyte and 
lyse bacteria to prevent lateral and apical expansion of 
the bacterial plaque, while the complement system pro-
vides a rapid increase in the anti-inflammatory response 
and in antibodies produced by plasma cells during a pre-
vious exposure. If this reaction (i.e., the inflammatory 
response) is sufficient to control the disease, a limited 
gingivitis is the result and the defensive response of the 
organism has been adequate to prevent propagation of 
the infection. In certain circumstances, however, micro-
organisms can evade the defense systems or are so viru-
lent that they can overcome them and invade the tissue. 
A second line of defense is then activated in the immune 
response, composed of macrophages, lymphocytes, and 
cytokines able to act against the pathogens in a more 
specific manner (11).
Diabetes as a risk factor for periodontal disease
Many authors have described diabetes as a risk factor 
for periodontal disease. Hence, Mealey concluded that 
diabetic patients had a three-fold higher risk of peri-
odontal disease compared with non-diabetic patients 
after controlling for age, sex, and other confounding 
factors (5).
For diabetes to be acknowledged as a risk factor it must 
meet the risk analysis criteria set out by Johnson & Hill, 
especially the two following conditions (12):
1) biological plausibility that the factor can cause a giv-
en disease by a known action mechanism, and
2)  demonstration in prospective studies that the factor 
chronologically precedes the disease. 
Longitudinal and cross-sectional studies are still need-
ed to confirm this association. There must be known 
mechanism(s) by which the factor can give rise to the 
effect, as we shall discuss in more detail below. Con-
sequently, the evidence is still weak and no causal rela-
tionship between periodontal disease and diabetes has 
been established.
Interrelationship between diabetes and peri-
odontal disease
Diabetes mellitus is, as previously stated, a systemic 
disease associated with serious complications that can 
affect the quality of life and life expectancy of the 
patient (12,13). There can be damage to the eyes and 
the nervous, cardiovascular, and renal systems and 
impairment of wound healing (2). Besides these well-
documented secondary effects, there are reports of an 
increased risk of periodontal disease or of its greater 
severity in patients with diabetes (3,12,14). For example, 
studies on Pima Indians in Arizona showed that loss of 
periodontal attachment and bone loss were greater in 
diabetic versus non-diabetic individuals within differ-
ent age groups (15,16).
Possible mechanisms underlying this association be-
tween periodontal disease and diabetes are currently 
under investigation and remain somewhat controversial. 
Some authors have described a possible common origin 
of the two diseases (17), whereas others consider that 
diabetes produces a hyper-inflammatory phenotype in 
certain cells due to the action of AG�s  (4,12,18). We 
briefly discuss some of the mechanisms proposed to 
underlie  interaction between diabetes and periodontal 
disease.
Both diabetes and periodontal disease are considered to 
have a hereditary component (18), and a large number of 
cases have been related to a given family pattern. How-
ever, it has not yet proved possible to relate these dis-
eases to any specific genetic mutation or disorder, and 
both diseases can therefore be described as polygenic.
Genetic factors evidently play a major role in suscep-
tibility to these diseases. However, the complex inter-
actions in periodontal disease between host response 
mechanisms and the action of pathogenic microorgan-
isms hamper clarification of the role of genetic factors 
(17). Nevertheless, an association has been observed 
between both diseases and an HLA genotype. The HLA 
molecule (human major histocompatibility locus mol-
ecule) is genetically determined on chromosome 6, and 
disorders in this chromosome appear to predispose the 
host to both diabetes and periodontitis by altering an-
tigen presentation to T cells and therefore the specific 
immune response of the patient (17). However, more 
studies are required in this area before conclusions can 
be drawn. 
The role of the immune system in the etiopathogeny of 
diabetes and periodontal disease is well documented 
(17). No doubt remains about the importance of the con-
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trolled release of cytokines and soluble factors that limit 
the noxious effects of both diseases. 
A further possible connection between the diseases ap-
pears to be the hyper-inflammatory phenotype observed 
in the patients. Patients with diabetes type-1 or -2 or 
periodontal disease show an imbalance or hyper-release 
of soluble cytokines against the attack of coadjuvant 
factors (13). The other risk factors include tobacco use 
or stress for periodontal disease and the action of virus-
es or toxic agents for diabetes. In response to the pres-
ence of these modifying factors, cells of both diabetic 
and periodontal patients release an increased amount 
of certain cytoactive chemicals e.g., prostaglandin �2 
(PG�2), interleukin 1 (IL-1), and tumor necrosis factor-
alpha (TNF-α). This up-regulation of immune response 
mediators has been demonstrated in vitro and in com-
parisons between diseased animals and healthy controls 
and may represent another possible explanation for the 
association between the two diseases (5). 
The first hypothesis on the diabetes-periodontal disease 
relationship derives from a combination of the above 
theories. Thus, it is proposed that a faulty combination 
of genes in chromosome 6 renders the host more sus-
ceptible to external factors that can give rise to diabetes 
and/or periodontal diseases if immunological and other 
defense mechanisms fail (17).
Besides the mainly genetic theories discussed above, 
other explanations of the interaction between the two 
diseases have been proposed  based on the binding of 
AG�s to their cell receptors (RAG�s) (4), which are 
present in certain diabetic patients, e.g., in endothelial 
or phagocytic cells (15). Hence, AG�s may be deposited 
on mononuclear or polymorphonuclear cells, inhibiting 
their chemotactic and phagocytic capacities and permit-
ting the advance of gram-negative anaerobic bacteria, 
which would explain the higher prevalence and sever-
ity of periodontal disease in diabetic patients (4). Ac-
cording to this theory, AG�-stimulated macrophages 
and polymorphonuclear cells show a hyper-response to 
the progression of bacterial biofilm, releasing a larger 
amount of cytokines and soluble mediators and produc-
ing a greater destruction of connective tissue in these 
patients (Fig. 1). 
Binding between AG�s and their receptors has also been 
observed in fibroblasts, which would have repercus-
sions for collagen, the main component of periodontal 
tissue. Accordingly, interference with the collagen turn-
over would impair wound-healing in diabetic patients 
and may reduce the resistance of periodontal tissues to 
bacterial attack  (2). It has also been demonstrated that 
AG�s increase collagenase and other enzyme activity 
in connective tissue, thereby contributing to tissue de-
struction. 
Matrix metalloproteinases (MMPs) are locally in-
creased in periodontal disease-affected gingival pock-
ets, and advanced periodontal disease has been asso-
ciated with elevated salivary MMP levels. Periodontal 
patients also have increased serum MMPs, which may 
be specifically due to infection with certain periodontal 
pathogens. It has been proposed that MMP-9 may link 
periodontal disease with cardiopathogenesis.(19) 
To summarize, it has been shown, in a biologically plau-
sible manner, how the host defense capacity can be al-
tered in diabetes. The bacterial species in the periodon-
tium are the same in diabetic and non-diabetic patients, 
suggesting that the increased periodontal disease risk in 
diabetic patients derives from an AG�-generating im-
munologic disorder (2). In turn, periodontal pathogens 
cause the up-regulation of cytokines and tissue degrad-
ing enzymes, which may also have systemic conse-
quences (20).
Periodontal disease as a risk factor for diabetes
Recognition of subgingival plaque as a microbial bio-
film has substantially added to our understanding of 
the pathophysiology of periodontal disease. In micro-
bial biofilms, bacteria are embedded in an extracellular 
matrix and adhere to one another and/or to a surface 
(19). Bacterial adhesion is essential to establish the sub-
gingival biofilm, and the pathogenic potential of this 
biofilm is determined by the growth and maturation of 
the bacteria in question. These bacteria constantly expel 
part of their cell structure components into the crev-
icular space. The cell wall structures of Gram-negative 
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Fig. 1. Model depicting how diabetes mel-
litus could contribute to the development of 
periodontal disease. The binding of AG�s to 
their receptors triggers a cascade of events that 
produce the destruction of connective tissue. 
AG�= advanced glycation end product, RAG� 
= receptor for AGE, TNFα = tumor necrosis 
factor alpha, IL-1β = interleukin-1 beta, MMP 
= matrix metalloproteinase. Modified from 
Grossi and Genco (3).
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bacteria are of major importance in the pathogenesis of 
periodontal disease. These structures are lipopolysac-
charides and vesicles with protein content that form part 
of the normal turnover of the cell wall of these microor-
ganisms and can activate the innate host response. The 
structure of the biofilm provides highly favorable condi-
tions for the survival of the bacteria that form it, despite 
an intact host immune system. The virulence factors of 
these microorganisms are responsible for triggering the 
sequence of pathogenic events in periodontal disease. 
Periodontal micro-organisms, in particular Porphyrom-
onas gingivalis (P.g.) and Tannerella forsythia (T.f.), 
were found to increase MMP-9 in gingival crevicular 
fluid and serum (20). 
According to the pathogenic model proposed in (Fig. 2), 
periodontal disease might increase the already elevated 
cytokine levels in diabetic patients and thereby contrib-
ute to systemic inflammation.
�xcessive formation and accumulation of AG�s in tis-
sues is the most common cause of diabetic complica-
tions. The binding of these molecules to neutrophils 
produces a hyperinflammatory state that amplifies the 
response to cytokines. These previously activated neu-
trophils also show a heightened response on making 
contact with LPS of gram-negative bacteria (e.g., P.g.) 
in the subgingival biofilm, and the consequent trigger-
ing of the inflammatory cascade increases the destruc-
tion of periodontal connective tissue and the severity of 
diabetes (14). 
Periodontal treatment and glycemic control in 
diabetics 
Although the relationship between diabetes and periodon-
tal disease is not questioned in the current literature, the 
effect of the metabolic control of diabetes on periodontal 
disease and the effect of periodontal treatment on metabol-
ic control in diabetic patients remains controversial. (Table 
1) summarizes recent meta-analyses on this issue. 
In general, however, periodontal treatment is a high pri-
ority in patients for whom periodontal disease may pose 
a health risk, and this includes diabetic patients. Proto-
cols have been described for the treatment and preven-
tion of infections in diabetic patients, mainly to control 
acute infections; the treatment of chronic infections ap-
pears to be significantly less effective.
Studies of mechanical treatment combined with system-
ic antibiotic therapy
A number of recent studies evaluated whether the use of 
systemic antibiotics improved the periodontal prognosis 
and metabolic control in diabetic patients. Mechanical 
periodontal therapy with 100 mg doxycycline produced 
a 0.6% reduction in HbA1c in type-2 diabetic patients.
Tetracyclines and their derivatives appear to play a 
relevant role in the inhibition of tissue destruction en-
zymes. Hence, doxycycline appears to be a potent mod-
ifier of the response to periodontal treatment in diabetic 
patients by inhibiting non-enzymatic glycosylation of 
extracellular proteins, suggesting that it has a similar 
effect on hemoglobin glycosylation.
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Table 1.  Characteristics and findings of intervention studies published on the periodontal disease – diabetes 
axis. Adapted from Janket.(20). 
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 References with links to Crossref - DOI    Conclusions
Results of published research in type-1 diabetic patients 
do not allow definitive conclusions to be drawn on the ef-
fects of periodontal treatment on glycemic control. This 
may be explained by the different etiologies of type 1 
and type 2 diabetes and by the strict control maintained 
during insulin treatment. Thus, researchers have found 
no differences in HbA1c after periodontal treatment of 
type-1 diabetic patients. Therefore, studies on the inter-
relationship between diabetes and periodontal disease 
should focus on type-2 diabetes, since the two entities 
are usually found in the same sub-population. The me-
ta-analysis was only able to confirm an improvement 
in metabolic control by the application of doxycycline 
gel. We therefore strongly support the call for further 
research to elucidate this issue before definitive conclu-
sions can be drawn. 
Given the interrelationship between diabetes and peri-
odontal disease, it is important to establish a good com-
munication between the specialist responsible for a 
diabetic patient and the patient’s dentist. Although the 
association between these diseases is now accepted as 
a reality, the clinical implications need to be adequately 
investigated. Importantly, the possibility of the simulta-
neous presence of the two diseases should be borne in 
mind to ensure their early diagnosis.
In view of the very high prevalence of both diseases 
and their potentially severe repercussions, the medical 
specialist should play a leading role in encouraging dia-
betic patients to visit their dentists regularly to control 
detrimental factors, such as the sustained presence of 
bacterial plaque in the periodontal pocket. Likewise, 
oral health personnel should bear in mind that impaired 
sugar metabolism and diabetes can affect the outcome 
and severity of periodontal disease. (Table 2)  outlines 
the types of study required to advance our knowledge 
and understanding of this issue.
 
Study question Type of research needed 
Prevalence of periodontal disease in diabetic populations. 
Periodontal disease and metabolic syndrome. 
�ffect of periodontal treatment on sugar metabolism. 
Periodontal pathogens and diabetes. 
Genetics of periodontal disease and diabetes. 
Clinical and epidemiological studies in wide samples of 
both type-1 and type-2 diabetic patients. 
Clinical and epidemiological studies with adequate 
samples, probably requiring a multi-center approach. 
Clinical intervention studies with randomized controlled 
trial design to assess different treatment modes. 
Clinical, microbiological, and biochemical studies. 
Molecular biological studies to assess the role of genetics 
in the development of the diseases. 
Table 2.  Suggestions for future research on periodontal disease – diabetes.
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